z-logo
open-access-imgOpen Access
mTOR Inhibition: From Aging to Autism and Beyond
Author(s) -
Matt Kaeberlein
Publication year - 2013
Publication title -
scientifica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.474
H-Index - 21
ISSN - 2090-908X
DOI - 10.1155/2013/849186
Subject(s) - pi3k/akt/mtor pathway , context (archaeology) , biology , phenotype , neuroscience , mtorc2 , signal transduction , bioinformatics , computational biology , psychology , microbiology and biotechnology , genetics , gene , mtorc1 , paleontology
The mechanistic target of rapamycin (mTOR) is a highly conserved protein that regulates growth and proliferation in response to environmental and hormonal cues. Broadly speaking, organisms are constantly faced with the challenge of interpreting their environment and making a decision between “grow or do not grow.” mTOR is a major component of the network that makes this decision at the cellular level and, to some extent, the tissue and organismal level as well. Although overly simplistic, this framework can be useful when considering the myriad functions ascribed to mTOR and the pleiotropic phenotypes associated with genetic or pharmacological modulation of mTOR signaling. In this review, I will consider mTOR function in this context and attempt to summarize and interpret the growing body of literature demonstrating interesting and varied effects of mTOR inhibitors. These include robust effects on a multitude of age-related parameters and pathologies, as well as several other processes not obviously linked to aging or age-related disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom